The American Academy of Pediatrics states it is "premature to recommend the administration of activated charcoal" as an alternative to ipecac syrup to treat ingestion of a potentially poisonous substance in a Nov. 3 1policy statement. Charcoal is "poorly accepted by young children" and does not store well in the home, the statement says. However, AAP adds that ipecac should "no longer be used routinely as a home treatment strategy" either. The use of activated charcoal in conjunction with ipecac syrup was discussed at Nonprescription Drugs Advisory Committee's June 2003 meeting on retaining ipecac's current OTC status (2"The Tan Sheet" June 2, 2003, p. 5)...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
• By Rachel Raphael, Elizabeth Bresnahan and Kathryn Ignash
Guest authors Rachel Raphael, partner at Morgan, Lewis & Bockius, LLP and associates at the firm, Elizabeth Bresnahan and Kathryn Ignash, advise beauty companies on how to navigate the legal risks associated with consumers ‘off-label’ beauty hacks.
Modifications to forms FDA 3500, for voluntary reporting by healthcare professionals, and 3500A, for mandatory reporting by manufacturers, marketers or facilities, include limiting changing gender question to sex and asking for only male or female answer.